Our product range comprises several specialised lock solutions to meet the individual needs of every patient. With 500 IU/ml of heparin, TauroLock™-HEP500 is designed to minimise occlusion rates throughout dialysis treatment.
Indication and effect
TauroLock™-HEP500 can be used with devices for venous vascular access. We recommend using it with catheters for haemodialysis. This lock solution prevents the formation of bacterial biofilm: Patients remain protected against catheter-related infections and maintain a high patency rate.
TauroLock™-HEP500 consists of three active ingredients:
- heparin (500 units per ml)
- citrate (4 %)
Taurolidine has a broad antimicrobial activity (incl. MRSA and VRE) against gram-positive and gram-negative bacteria and fungi (e.g. Candida). Heparin and citrate both prevent occlusions within the catheter.
In-between treatment sessions, TauroLock™-HEP500 is instilled into the vascular access system. Please note that medical staff have to check the filling volume of the respective catheter or port system.